The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of breast cancer receptor subtypes and CSF cytology status on survival for patients with leptomeningeal disease.
 
Sujan Niraula
No Relationships to Disclose
 
Sugam Gouli
No Relationships to Disclose
 
Andrea M. Baran
No Relationships to Disclose
 
Haley Tyburski
No Relationships to Disclose
 
Huina Zhang
No Relationships to Disclose
 
Ruth O'Regan
Honoraria - AstraZeneca/MedImmune; bioTheranostics; Gilead Sciences; Novartis; Pfizer; Puma Biotechnology; Seagen
Consulting or Advisory Role - AstraZeneca/MedImmune; bioTheranostics; Lilly; Novartis; Puma Biotechnology; seagen
Research Funding - Novartis (Inst); Puma Biotechnology (Inst)
 
Nimish Mohile
No Relationships to Disclose
 
Carey K. Anders
Honoraria - AstraZeneca; Athenex; Eisai; Elucida Oncology; Genentech/Roche; Immunomedics; IPSEN; Novartis; Puma Biotechnology; Seagen
Consulting or Advisory Role - AstraZeneca; Athenex; Eisai; Elucida Oncology; Genentech/Roche; Immunomedics; Ipsen; Roche; Seagen
Research Funding - AstraZeneca (Inst); Caris Life Sciences (Inst); Elucida Oncology (Inst); G1 Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Seagen (Inst); Tesaro (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlett; Up to Date.com
Travel, Accommodations, Expenses - Eisai
 
Sara Hardy
No Relationships to Disclose
 
Ajay Dhakal
Honoraria - AstraZeneca; Gilead Sciences; OncLive/MJH Life Sciences; OncLive/MJH Life Sciences; WebMD/Medscape
Research Funding - Celcuity; Puma Biotechnology